Abstract
For medial compartment disease UKR has many advantages over TKR. They give better function, faster recovery, lower morbidity and mortality but have a higher revision rate. Matched studies from the England and Wales National Joint Registry showed they are 60% more likely to achieve excellent outcomes (OKS>41) and 30% more likely to have excellent satisfaction. UKR patients were discharged 1.4 days earlier, had 35% less readmissions and 50% less major complications such as DVT/PE, infection, CVA and MI. The death rate was significantly lower: The hazard ratios being 0.2x at 30 days, 0.5x at 90 days and 0.85x at 8 years. However at 8 years the revision rate was 2x higher and the reoperation rate was 1.4x. If 100 patients receiving TKR had UKR instead, the result would be around one fewer death and three more reoperations in the first 4 years. If patients were aware of this most would select a UKR.
The main reason why UKR have a high revision rate in registries is that most surgeons do small numbers and restrict their use to patients with very early disease, who often do badly. In the NJR 8% of knees are UKR and surgeons do on average 5 per year. Surgeons doing more than 20% of knees as UKR have a much lower re-operation rate which is similar to that of TKR. The Mobile bearing UKR can safely be used in up to 50% allowing many patients to have the advantages of UKR and a low re-operation rate.
